1 – 10 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis : A Nested Case-Control Study with Matched Cases and Controls
(
- Contribution to journal › Article
- 2020
-
Mark
GDNF and Parkinson's Disease : Where Next? A Summary from a Recent Workshop
(
- Contribution to journal › Article
- 2014
-
Mark
Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Review: The future of cell therapies and brain repair: Parkinson's disease leads the way.
(
- Contribution to journal › Scientific review
-
Mark
Is Exenatide the Next Big Thing in Parkinson's Disease?
(
- Contribution to journal › Article
-
Mark
Long-term clinical outcome of fetal cell transplantation for Parkinson disease : two case reports
(
- Contribution to journal › Article
-
Mark
The role of Galectin-3 in α-synuclein-induced microglial activation
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
(
- Contribution to journal › Scientific review
- 2011
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Membrane Interaction of α-Synuclein in Different Aggregation States
(
- Contribution to journal › Article